Trials / Active Not Recruiting
Active Not RecruitingNCT02538198
Lenalidomide Maintenance in Plasma Cell Myeloma
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 108 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase 2 study to assess the good and bad effects of maintenance therapy on patients who have been treated for myeloma and no longer show signs of this type of cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lenalidomide |
Timeline
- Start date
- 2015-08-31
- Primary completion
- 2026-08-01
- Completion
- 2026-08-01
- First posted
- 2015-09-02
- Last updated
- 2025-07-03
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02538198. Inclusion in this directory is not an endorsement.